Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes

$427,050U01FY2006DKNIH

La Jolla Institute For Immunology, La Jolla CA

Investigators

Matthias G. Von Herrathcontact

Linked publications & trials

Paper 25393309 Paper 24582317 Paper 24520125 Paper 23770292 Paper 22063316 Paper 21832162 Paper 21289271 Paper 21248163 Paper 21162649 Paper 20932718 Paper 19162441 Paper 17412305

View original record on NIH RePORTER →